| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/14/2007 | WO2007067683A2 Methods and compositions for expanding t regulatory cells |
| 06/14/2007 | WO2007067596A2 Methods and compositions for needleless delivery of antibodies |
| 06/14/2007 | WO2007067517A2 Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants |
| 06/14/2007 | WO2007067512A2 Method for identifying modulators of adprh useful for treating alzheimer's disease |
| 06/14/2007 | WO2007066823A1 Antibody against connective tissue growth factor or composition containing the same |
| 06/14/2007 | WO2007066698A1 Genetically recombinant anti-perp antibody |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |
| 06/14/2007 | WO2007066334A1 Improved influenza vaccine |
| 06/14/2007 | WO2007066106A1 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 06/14/2007 | WO2007065967A1 A vaccine suitable for use against the next influenza a pandemia |
| 06/14/2007 | WO2007065957A2 Methods for generating antigen-specific effector t cells |
| 06/14/2007 | WO2007065633A1 Modulation of the immune response by administration of intralymphatic transduction allergen (itag) -molecules |
| 06/14/2007 | WO2007065439A1 Method for generating dendritic cells employing decreased temperature |
| 06/14/2007 | WO2007065215A1 Treatment of epstein-barr virus-associated diseases |
| 06/14/2007 | WO2007051004A3 Conjugate vaccines for non-proteinaceous antigens |
| 06/14/2007 | WO2007044406A3 Methods for stimulating an immune response using bacterial antigen delivery system |
| 06/14/2007 | WO2007036735A3 Immunogenic agents againts burkholderia psudomallei and/or burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from burkholderia psuedomallei |
| 06/14/2007 | WO2007034210A3 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 06/14/2007 | WO2007034188A3 Chemo-immunotherapy method |
| 06/14/2007 | WO2007028047A3 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 06/14/2007 | WO2007027640A3 Stabilized virus-like particles and epitope display systems |
| 06/14/2007 | WO2007024921A3 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 06/14/2007 | WO2007019411A3 Peptides for diagnostic and therapeutic methods for celiac sprue |
| 06/14/2007 | WO2007011896A3 Method to inhibit proliferation and growth of metastases |
| 06/14/2007 | WO2007011856A3 Compositions and methods for differential diagnosis of chronic lymphocytic leukemia |
| 06/14/2007 | WO2007011746A3 Highly sensitive immunoassays and antibodies for detection of blood factor viii |
| 06/14/2007 | WO2007002525A3 Tomoregulin antibodies and uses thereof |
| 06/14/2007 | WO2006136460A3 New adjuvant |
| 06/14/2007 | WO2006113723A3 Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease |
| 06/14/2007 | WO2006113614A3 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
| 06/14/2007 | WO2006113372A3 Porcine circovirus and helicobacter combination vaccines |
| 06/14/2007 | WO2006073982A3 Bispecific molecule comprising ligands for cell-surface protein and t-cell surface protein |
| 06/14/2007 | WO2006065533A3 Engineered antibodies and immunoconjugates |
| 06/14/2007 | WO2006034507A3 Methods of diagnosing and treating complications of pregnancy |
| 06/14/2007 | WO2006004736A3 Stable liquid and lyophilized formulation of proteins |
| 06/14/2007 | WO2005016236A3 Antibodies that immunospecifically bind to trail receptors |
| 06/14/2007 | US20070136896 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein |
| 06/14/2007 | US20070136833 Genes encoding several poly (ADP-RIBOSE) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070135413 Treatment of glial tumors with glutamate antagonists |
| 06/14/2007 | US20070135337 Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases |
| 06/14/2007 | US20070134762 Immunogenic peptide carrier conjugates and methods of producing same |
| 06/14/2007 | US20070134744 Epothilone resistant cell lines |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134719 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 06/14/2007 | US20070134711 Compositions of eleutherosides capable of modulating protein expresion |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134313 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 06/14/2007 | US20070134312 Liposomes for treatment of multiple myeloma |
| 06/14/2007 | US20070134275 Medicaments for the immunotherapy of malignant tumors |
| 06/14/2007 | US20070134274 Vaccine candidates against Johne's disease |
| 06/14/2007 | US20070134273 Composition and method for the treatment of carcinoma |
| 06/14/2007 | US20070134272 Mannheimia haemolytica chimeric outer membrane protein PIpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever |
| 06/14/2007 | US20070134271 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 06/14/2007 | US20070134270 Chicken rna polymerase i promoter and the use thereof |
| 06/14/2007 | US20070134269 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 06/14/2007 | US20070134268 Vaccines |
| 06/14/2007 | US20070134267 Tuberculosis vaccine with improved efficacy |
| 06/14/2007 | US20070134264 Helicobacter System And Uses Thereof |
| 06/14/2007 | US20070134263 Grampositive immunogen protein for use in developing vaccine for prevention of microorganismal infection; immunization |
| 06/14/2007 | US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus |
| 06/14/2007 | US20070134261 Effectors of innate immunity |
| 06/14/2007 | US20070134260 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 06/14/2007 | US20070134259 Methods and compositions for pharmacologially controlled targeted immunotherapy |
| 06/14/2007 | US20070134258 Gasp1: a follistatin domain containing protein |
| 06/14/2007 | US20070134257 Metal-binding therapeutic peptides |
| 06/14/2007 | US20070134256 Chimpanzee Fab antibodies against DENV-4; isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith |
| 06/14/2007 | US20070134255 Hmpv treatment with ribavirin and anti-hmpv antibody |
| 06/14/2007 | US20070134254 antibodies that immunospecifically bind to tyrosine kinase receptors (EphA2) and competes for binding to EphA2 with the EA5 antibody, used for cancer therapy |
| 06/14/2007 | US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas |
| 06/14/2007 | US20070134252 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors |
| 06/14/2007 | US20070134251 Detection of expression of biomarkers is predictive or indicative that the tissue or cell sample will be sensitive to apoptosis-inducing agents such as Apo2L/TRAIL and anti-DR5 agonist antibodies; fucosyltransferase 3 (FUT3) and/or fucosyltransferase 6 (FUT6); |
| 06/14/2007 | US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3 |
| 06/14/2007 | US20070134249 Combination therapy and antibody panels |
| 06/14/2007 | US20070134248 Combination therapy and antibody panels |
| 06/14/2007 | US20070134247 Prevention of brain inflammation as a result of induced autoimmune response |
| 06/14/2007 | US20070134246 Antibodies to TGF-BETA |
| 06/14/2007 | US20070134245 Rankl antibody-PTH/PTHrP chimeric molecules |
| 06/14/2007 | US20070134244 Combination treatment for pathologic ocular angiogenesis |
| 06/14/2007 | US20070134243 Antibody drug conjugates and methods |
| 06/14/2007 | US20070134242 Mesothelioma therapeutic agent |
| 06/14/2007 | US20070134241 Humanized anti-CD3 specific antibodies |
| 06/14/2007 | US20070134240 Use of a CD28 binding substance for making a pharmaceutical composition |
| 06/14/2007 | US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134237 Human cytokine receptor |
| 06/14/2007 | US20070134236 Humanized antibodies against monocyte chemotactric proteins |
| 06/14/2007 | US20070134235 Endothelialization of vascular surfaces |
| 06/14/2007 | US20070134234 Immunomodulatory compositions and uses therefor |
| 06/14/2007 | US20070134233 Compositions and methods relating to organ-, tissue-, and cell-specific antibodies |
| 06/14/2007 | US20070134228 Immunoaffinity purification |
| 06/14/2007 | US20070134219 Antigen presenting cells; immunogens |
| 06/14/2007 | US20070134214 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 06/14/2007 | US20070134212 Engrafting foreign replacement cells within fetal non-human mammal by selectively destroying native cells in tissue of fetal non-human mammal host, wherein number of maternal cells of same tissue is not substantially reduced; thereafter implanting foreign replacement cells in tissue of fetal mammal host |
| 06/14/2007 | US20070134200 Immunogenic composition and methods |
| 06/14/2007 | US20070134199 a surface active substance, in particular a non-ionic detergent (tenside), and a mixture of at least two amino acids, are either Glu and Gln or Asp and Asn for stabilization of protein agents in pharmaceuticals |
| 06/14/2007 | US20070134170 Porphyromonas gingivalis 1435/1449 LPS as an immune modulator |
| 06/14/2007 | US20070134158 Method for comparing multiple botulinum neurotoxins |
| 06/14/2007 | DE10297513B4 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |